On Tuesday, Colorado-based remote patient monitoring company BioIntelliSense announced the acquisition of AlertWatch, a monitoring platform. AlertWatch aggregates data and provides clinicians with a composite view of patient vital sign trends.
The company received four FDA 510(k) clearances for its product offerings for operating rooms, labor and delivery units, and intensive care units....
Remote patient monitoring company BioIntelliSense scored $45 million in a Series B funding round. To date, the Colorado-based startup has raked in roughly $82 million.
Chimera (UAE) led the round with participation from 7wire Technology Partners, Mary Tolan of Chicago Pacific Founders, James Murren, formerly of MGM Resorts International, as well as Pendrell Corporation, Royal Philips and...
